MAP1LC3A and infection: Therefore, ABT-263 and an autophagy inhibitor synergistically inhibited the survival effects of BCL-XL and LC3 induced in reactivated latently infected T cells, facilitating cell death upon ARV treatment to prevent new infections [17].